AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $3.42M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 10.07am 31/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
| Daily Volume | 0 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 4.8¢ | 0 | 0 | 5.5¢ | 255464 | |
Directors & Senior Management
| Mr. Bevan Nigel Hugh Tarratt | Director |
| Mr. Brent Van Staden | Non-Executive Director |
| Mr. David Grant Sanders | Independent Non-Executive Director |
| Mr. Ian Kelso | Exploration Manager |
| Dr. Julian Rodney Stephens | Executive Director |
| Mr. Quinton James Meyers | CFO & Company Secretary |
Data source: ADVFN
